181 related articles for article (PubMed ID: 31202518)
21. The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor.
Garvin AJ; Sullivan JL; Bennett DD; Stanley WS; Inabnett T; Sens DA
Am J Pathol; 1987 Nov; 129(2):353-63. PubMed ID: 2445211
[TBL] [Abstract][Full Text] [Related]
22. "Teratoid" Wilms Tumor: The Extreme End of Heterologous Element Differentiation, Not a Separate Entity.
D'Hooghe E; Mifsud W; Vujanić GM
Am J Surg Pathol; 2019 Nov; 43(11):1583-1590. PubMed ID: 31600178
[TBL] [Abstract][Full Text] [Related]
23. Histological analysis of aggressiveness and responsiveness in Wilms' tumor.
Beckwith JB; Zuppan CE; Browning NG; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):422-8. PubMed ID: 8827069
[TBL] [Abstract][Full Text] [Related]
24. Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine.
Markovsky E; Vax E; Ben-Shushan D; Eldar-Boock A; Shukrun R; Yeini E; Barshack I; Caspi R; Harari-Steinberg O; Pode-Shakked N; Dekel B; Satchi-Fainaro R
Mol Cancer Ther; 2017 Nov; 16(11):2462-2472. PubMed ID: 28729402
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
Oncotarget; 2017 Feb; 8(7):11173-11186. PubMed ID: 28061436
[TBL] [Abstract][Full Text] [Related]
26. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.
Shukrun R; Pode Shakked N; Dekel B
Pediatr Nephrol; 2014 May; 29(5):815-23; quiz 821. PubMed ID: 23760992
[TBL] [Abstract][Full Text] [Related]
28. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor.
Sehic D; Ciornei CD; Gisselsson D
Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327
[TBL] [Abstract][Full Text] [Related]
30. Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture.
Wojcik HM; Lovvorn HN; Hollingshead M; Pierce J; Stotler H; Murphy AJ; Borgel S; Phelps HM; Correa H; Perantoni AO
Front Oncol; 2023; 13():1091274. PubMed ID: 37007076
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies.
Vujanić GM; D'Hooghe E; Graf N; Vokuhl C; Al-Saadi R; Chowdhury T; Pritchard-Jones K; Furtwängler R
Int J Cancer; 2021 Sep; 149(6):1332-1340. PubMed ID: 34109628
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
33. MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27(Kip1) protein expression in nephroblastoma.
Ghanem MA; Van der Kwast TH; Sudaryo MK; Mathoera RB; van den Heuvel MM; Al-Doray AA; Nijman RM; van Steenbrugge GJ
Clin Cancer Res; 2004 Jan; 10(2):591-7. PubMed ID: 14760081
[TBL] [Abstract][Full Text] [Related]
34. Presence of the long chain form of polysialic acid of the neural cell adhesion molecule in Wilms' tumor. Identification of a cell adhesion molecule as an oncodevelopmental antigen and implications for tumor histogenesis.
Roth J; Zuber C; Wagner P; Blaha I; Bitter-Suermann D; Heitz PU
Am J Pathol; 1988 Nov; 133(2):227-40. PubMed ID: 2461089
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
[TBL] [Abstract][Full Text] [Related]
36. A multi-Gaussian model for apparent diffusion coefficient histogram analysis of Wilms' tumour subtype and response to chemotherapy.
Hales PW; Olsen ØE; Sebire NJ; Pritchard-Jones K; Clark CA
NMR Biomed; 2015 Aug; 28(8):948-57. PubMed ID: 26058670
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms' tumor.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
J Pediatr Surg; 2017 Aug; 52(8):1348-1354. PubMed ID: 28040201
[TBL] [Abstract][Full Text] [Related]
38. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
39. Aspiration cytology of Wilms' tumor: correlation of cytologic and histologic features.
Akhtar M; Ali MA; Sackey K; Sabbah R; Burgess A
Diagn Cytopathol; 1989; 5(3):269-74. PubMed ID: 2551617
[TBL] [Abstract][Full Text] [Related]
40. Outcome of Children with Wilms' Tumor in Developing Countries.
Bahoush G; Saeedi E
J Med Life; 2020; 13(4):484-489. PubMed ID: 33456596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
